Our news

  • PaPaS is part of the Cochrane Musculoskeletal, Oral, Skin and Sensory (MOSS) Network. A short film has been made which introduces the team, talks about what has happened so far, and the ambition for what is to come. Watch it here.
    July 16 2019
  • On the 20th June 2019, we published an overview review in the PAIN Journal on the efficacy of pharmacological interventions for children with chronic pain and cancer-related pain (https://bit.ly/313YmCj). The overview summarises the evidence from 23 systematic reviews, including several PaPaS reviews from our NIHR Programme Grant (https://papas....
    June 27 2019
  • We are delighted to announce our successful bid for Cochrane's Network Innovation funding. Read more about the initiative launched earlier this year here. Find out more about our project "Optimal methods for the use of ‘pain’ as an outcome in systematic reviews of postoperative pain management" here.
    June 17 2019
  • Can you help? We're looking for existing priorities in acute pain, chronic pain, headache & migraine, and palliative care. Please get in touch if you know of any relevant projects, completed or ongoing. Thank you! Read about our 2019 prioritisation plans here.
    June 17 2019
  • Our email addresses have changed, please find our new email addresses below:joanne.abbott@ouh.nhs.ukanna.erskine@ouh.nhs.ukkerry.harding2@ouh.nhs.uk 
    June 4 2019
  • Cochrane overviews of reviews (Cochrane Overviews) compile evidence from multiple systematic reviews of interventions into one document. You can find out more about this type of review in the Cochrane Handbook here.At PaPaS, we have produced 12 overviews, and we are pleased to share them on our wesbite here as a collection.
    June 4 2019
  • The Spanish version of the podcast for our review Cannabis-based medicine for chronic neuropathic pain in adults is now available.Listen to the podcast in Spanish here.
    April 30 2019
  • Sarah Chapman, from the UK Cochrane Centre, blogs about evidence from our review 'Pregabalin for neuropathic pain in adults'. Focussing on the benefits and harms of pregabalin for neuropathic pain and reflects on the experience of finding a balance between them. Read the blog post here, and the full review on the Cochrane Library here.
    April 9 2019
  • You may be aware that Cochrane has created eight new Networks responsible for the efficient and timely production of high-quality systematic reviews. Our Network has recently changed its name from ‘Long-term Conditions and Ageing 2’ to ‘Musculoskeletal, Oral, Skin and Sensory’ (MOSS). Read more about the consultation process below. Following...
    January 9 2019
  • *These vacancies are now closed*We would like to invite applications for this interesting and challenging opportunity to work with Cochrane’s global Networks. There are two vacancies: one in the area of Long-term Conditions and Ageing, and one in Acute and Emergency Care.Each Network requires a Network Support Fellow to support the efficient and...
    November 16 2018

Pages

Subscribe to Our news